Lv41
440 积分 2025-09-28 加入
Comparison of tucidinostat with CHOP-like versus CHOP-like in first-line treatment of peripheral T-cell lymphoma: a single-center real-world study
1个月前
已完结
siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway
1个月前
已完结
原发肠道非霍奇金淋巴瘤的临床特征及预后分析
1个月前
已关闭
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
2个月前
已完结
CXCL10 Recruitment of γδ T Cells into the Hypoxic Bone Marrow Environment Leads to IL17 Expression and Multiple Myeloma Progression
3个月前
已完结
Targeting RAS-mutant cancer cells using a synthetic RAS-activated cancer killing system
3个月前
已完结
Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma
4个月前
已完结
Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma
5个月前
已完结
B细胞易位基因1对耐利妥昔单抗的SU-DHL-2细胞的抑制作用
5个月前
已完结
B细胞易位基因1对B细胞淋巴瘤增殖的影响
5个月前
已完结
皖公网安备34019202002308
